Dong Sung Bio Pharm.Co.,Ltd. (002210.KS)
KRW 5320.0
(1.92%)
KRW 5320.0
(1.92%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -4.29 Billion | -3.88 Billion | -2.75 Billion | 5 Billion | -8.3 Billion | 1.39 Billion |
| Net Income | -2.07 Billion | -2.12 Billion | -4.31 Billion | -14.07 Billion | -8.38 Billion | -5.74 Billion |
| Depreciation & Amortization | 2.04 Billion | 2.11 Billion | 2.22 Billion | 2.09 Billion | 2.1 Billion | 1.98 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -5.16 Billion | -4.34 Billion | -2.54 Billion | 6.51 Billion | -5.84 Billion | 205.44 Million |
| Other non-cash items | 899.97 Million | 467.55 Million | 1.88 Billion | 10.47 Billion | 3.81 Billion | 4.94 Billion |
| Investing Cash Flow | -927.71 Million | 638.28 Million | -9.69 Billion | -5.63 Billion | 9.34 Billion | -19.06 Billion |
| Investments in PPE | -923.56 Million | -642.89 Million | -2.32 Billion | -6.92 Billion | -1.42 Billion | -2.12 Billion |
| Acquisitions | 18.18 Million | 74.33 Million | -197.72 Million | 2.14 Billion | -99.79 Million | 196.99 Million |
| Investment purchases | -57.53 Million | -56.17 Million | -10.99 Billion | -51.71 Billion | -73.6 Billion | -92.69 Billion |
| Sales/Maturities of investments | - | 2.01 Billion | 14.98 Billion | 49.94 Billion | 84.37 Billion | 75.77 Billion |
| Other Investing Activities | 35.19 Million | -756.9 Million | -11.17 Billion | 912.18 Million | 103.64 Million | -210.07 Million |
| Financing Cash Flow | 7.56 Billion | 4.24 Billion | 1.23 Billion | -3.3 Billion | 1.01 Billion | 15.81 Billion |
| Debt repayment | -1.22 Billion | -44.05 Billion | -26.43 Billion | -27.91 Billion | -27.58 Billion | -25.41 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | -1.99 Billion | -2.99 Billion | -2 Billion | - | - |
| Common Stock Issuance | - | - | 8.45 Billion | -1.35 Million | -26.3 Million | - |
| Other Financing Activities | 8.79 Billion | 50.28 Billion | 30.65 Billion | 26.61 Billion | 28.61 Billion | 41.22 Billion |
| Accounts receivables | 2.88 Billion | -4.28 Billion | -1.79 Billion | 4.83 Billion | 3.28 Billion | 2.01 Billion |
| Accounts payables | 1.51 Billion | 1.99 Billion | -2.87 Billion | -247.89 Million | -212.13 Million | -1.26 Billion |
| Inventory | -3.96 Billion | 629.71 Million | 4.46 Billion | 2.92 Billion | -6.13 Billion | -1.02 Billion |
| Other working capital | -5.6 Billion | -2.69 Billion | -2.34 Billion | -995.16 Million | -2.78 Billion | 1.23 Billion |
| Cash at beginning of period | 4.09 Billion | 3.14 Billion | 14.35 Billion | 18.36 Billion | 2.21 Billion | 4.04 Billion |
| Cash at end of period | 6.43 Billion | 4.09 Billion | 3.14 Billion | 14.35 Billion | 4.27 Billion | 2.21 Billion |
| Capital Expenditure | -923.56 Million | -642.89 Million | -2.32 Billion | -6.92 Billion | -1.42 Billion | -2.12 Billion |
| Effect of forex changes on cash | -4.7 Million | -42.27 Million | 7.56 Million | -83.4 Million | 14.92 Million | 21.19 Million |
| Net cash flow / Change in cash | 2.34 Billion | 953.61 Million | -11.21 Billion | -4.01 Billion | 2.06 Billion | -1.83 Billion |
| Free Cash Flow | -5.21 Billion | -4.52 Billion | -5.07 Billion | -1.91 Billion | -9.72 Billion | -733.54 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1.05 Billion | -163.39 Million | -2.07 Billion | -1.98 Billion | -44.65 Million | -812.87 Million |
| Depreciation & Amortization | 512.61 Million | 490.75 Million | 2.04 Billion | 525.24 Million | 480.85 Million | 537.48 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -1.88 Billion | -8.39 Billion | -5.16 Billion | 7.05 Billion | -5.77 Billion | -5.79 Billion |
| Other non-cash items | 498.41 Million | 3.08 Billion | 899.97 Million | 933.36 Million | -71.26 Million | 1.43 Billion |
| Investing Cash Flow | -1.87 Billion | -5.91 Million | -927.71 Million | -4.39 Billion | 1.72 Billion | 2.86 Billion |
| Investments in PPE | -374.67 Million | -357.06 Million | -923.56 Million | -214.04 Million | -316.96 Million | -192.35 Million |
| Acquisitions | 1.27 Million | - | 18.18 Million | 14.59 Million | - | - |
| Investment purchases | - | - | -57.53 Million | 14.59 Million | -35 Million | -14.04 Million |
| Sales/Maturities of investments | - | 280.87 Million | - | -14.59 Million | - | - |
| Other Investing Activities | -1.5 Billion | 70.26 Million | 35.19 Million | -4.19 Billion | 2.07 Billion | 3.07 Billion |
| Financing Cash Flow | 5.61 Billion | 3.44 Billion | 7.56 Billion | -2.35 Billion | 7.97 Billion | 1.99 Billion |
| Debt repayment | -5.64 Billion | -3.49 Billion | -1.22 Billion | -1.03 Billion | -13.41 Billion | -5.07 Billion |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -27.52 Million | -30 Million | 8.79 Billion | -1.32 Billion | 21.38 Billion | 7.06 Billion |
| Accounts receivables | 284.73 Million | -1.39 Billion | 2.88 Billion | 2.38 Billion | 64.24 Million | -3.08 Billion |
| Accounts payables | 785.37 Million | 2.47 Million | 1.51 Billion | -1.99 Billion | 705.63 Million | 1.84 Billion |
| Inventory | -1.04 Billion | -543.46 Million | -3.96 Billion | -225.69 Million | -991.78 Million | -1.38 Billion |
| Other working capital | -1.62 Billion | -6.45 Billion | -5.6 Billion | 6.88 Billion | -5.55 Billion | -3.18 Billion |
| Cash at beginning of period | 1.97 Billion | 6.43 Billion | 4.09 Billion | 6.66 Billion | 2.37 Billion | 2.16 Billion |
| Cash at end of period | 2.78 Billion | 1.97 Billion | 6.43 Billion | 6.43 Billion | 6.66 Billion | 2.37 Billion |
| Capital Expenditure | -374.67 Million | -357.06 Million | -923.56 Million | -214.04 Million | -316.96 Million | -192.35 Million |
| Effect of forex changes on cash | - | 58.27 Thousand | -4.7 Million | -7.27 Million | 2.04 Million | -3.74 Million |
| Net cash flow / Change in cash | 811.03 Million | -4.46 Billion | 2.34 Billion | -228.7 Million | 4.28 Billion | 217.66 Million |
| Free Cash Flow | -3.3 Billion | -8.25 Billion | -5.21 Billion | 6.31 Billion | -5.72 Billion | -4.83 Billion |
023530
6919
QMCQF
HTHIF
4890
023410